コンテンツへスキップ

CrestecBio|News

  • Home

Latest Post

Notice of Completion of Third-Party Allotment of New Shares Our CEO, Dr. Marushima, presented at the JHVS AMED Seeds Acceleration Pitch 2025. Our CEO, Dr. Marushima, presented at University of Tsukuba Night 2025 held in Boston. Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan. Our CEO, Dr. Marushima will attend The 31st Annual Meeting of the Japanese Society for Endovascular Intervention.
News

Accetped: CrestecBio was selected for the Strategic Innovation Program (SIP) of the Cabinet Office Phase 3 “Establishment of an Ecosystem for Material Commercialization Innovation and Development” under Subproject C “Creating a Reserve Army of Material Unicorns” Individual Theme (2) “Theme Mentoring.

2023-11-08 news_en

News

Our CEO Marushima will be a panelist at the 6th Venture Symposium launched from University of Tsukuba.

2023-11-06 news

https://www.sanrenhonbu.tsukub…

News

Our COO Masahiro Yamaji gave an invited lecture at BioJapan2023 from Chiyoda Corporation.

2023-10-11 news_en

https://biojapan2023.jcdbizmat…

News

Article: CrestecBio was featured in Nikkei Biotech. “Comprehensive List of Bio/Healthcare Startups 2023-2024”

2023-10-02 news_en

News

Our Business Development Advisor, Dr. Taruho Kuroda, gave a presentation on our business at the Japan Innovation Night event linked to the Bio International Convention 2023 (Boston, USA).

2023-06-08 news

Pitch event at the Japan Innov…

News

CrestecBio Raises Funds through J-KISS Type Stock Acquisition Rights

2023-05-09 news

CrestecBio Inc. (Head office: …

News

CrestecBio Inc. (Head office: Tsukuba, Ibaraki Prefecture, Japan; CEO: Aiki Marushima) has raised funds through the issuance of J-KISS type stock acquisition rights to Newsight Tech Angels, Inc.

2023-02-21 news

CEO Marushima received “BizDev…

News

Our project was adopted as a candidate for the Strategic Innovation Program (SIP).

2022-09-27 news

Our project was adopted as a c…

News

CrestecBio Inc. was adopted for the 2022 Ibaraki Prefecture Venture Business Growth Promotion Project (Growth Program).

2022-08-10 news

News

Company home page is now open.

2022-05-17 news

投稿のページ送り

1 2 3 4

Recent Posts

  • Notice of Completion of Third-Party Allotment of New Shares
  • Our CEO, Dr. Marushima, presented at the JHVS AMED Seeds Acceleration Pitch 2025.
  • Our CEO, Dr. Marushima, presented at University of Tsukuba Night 2025 held in Boston.
  • Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.
  • Our CEO, Dr. Marushima will attend The 31st Annual Meeting of the Japanese Society for Endovascular Intervention.

見逃しています

Uncategorized

Notice of Completion of Third-Party Allotment of New Shares

2025-12-09 news_en
News

Our CEO, Dr. Marushima, presented at the JHVS AMED Seeds Acceleration Pitch 2025.

2025-10-08 news_en
News

Our CEO, Dr. Marushima, presented at University of Tsukuba Night 2025 held in Boston.

2025-09-08 news_en
News

Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.

2025-05-25 news_en

CrestecBio|News

  • Home